Skip to main content

Table 5 GIPAP: Results of a Random Effects Ordered Probit Model - country breakdown

From: Benefits of global partnerships to facilitate access to medicines in developing countries: a multi-country analysis of patients and patient outcomes in GIPAP

 

Country Regressions

Model

India

China

Pakistan

Remaining 12 countries

Dependent Variable

Curphase

Curphase

Curphase

Curphase

 

Odds Ratio

SE

Odds Ratio

SE

Odds Ratio

SE

Odds Ratio

SE

Quarter

1.069***

0.006

1.089***

0.009

0.983

0.015

1.093***

0.006

Origphase

240.567***

0.104

21.052***

0.063

115.816***

0.165

18.102***

0.073

Ageatapproval

1.005***

0.002

0.998

0.002

1.016***

0.004

0.994***

0.003

Gender

1.012

0.057

1.021

0.066

1.141

0.106

0.933

0.063

Gap

0.996

0.004

1.001

0.003

0.985**

0.007

0.990***

0.003

Close

0.685***

0.086

0.691***

0.088

0.404***

0.196

0.694***

0.059

Log Likelihood

-6663.125

-4495.819

-1277.437

-6638.452

LR chi2(31)

4401.33

2278.68

660.41

1612.61

Observations

34,686

10,663

6,837

14,493

  1. Note: Significance levels: *** indicates significance at 1% level; ** at 5% level and * at 10% level.